R. Erik Holmlin - Mar 14, 2025 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role: President and CEO, Director
Signature: /s/ Jonathan V. Dixon, Attorney-in-Fact
Stock symbol: BNGO
Transactions as of: Mar 14, 2025
Transactions value $: -$687
Form type: 4
Date filed: 3/18/2025, 06:45 PM
Previous filing: Feb 19, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BNGO	Common Stock	Tax liability	-$687	-198	-9.99%	$3.47	1.78K	Mar 14, 2025	Direct	F1
holding	BNGO	Common Stock						8	Mar 14, 2025	Robert Erik Holmlin Traditional IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BNGO	Stock Option (Right to Buy)	Award	$0	+17.4K		$0.00	17.4K	Mar 14, 2025	Common Stock	17.4K	$3.47	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person is reporting the withholding by the Issuer of an aggregate of 198 shares of common stock in connection with shares that vested on March 14, 2025 pursuant to an PSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the PSU award.
F2	Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date.